Cell Therapy and Cell Engineering Facility
Kevin J. Curran
The Cell Therapy and Cell Engineering Facility develops, validates, and implements procedures critical to gene transfer-related clinical research at Memorial Sloan Kettering. The quality assurance and quality control unit (QA/QC) is essential for providing a laboratory environment compliant with NIH and FDA guidelines.
Testing CRISPR-Edited CAR T Cell Therapy in Lymphoma Clinical Trial
A groundbreaking clinical trial is testing CAR T cells created using CRISPR gene-editing technology.
Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy
An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.
Clinical Trial for Beta-Thalassemia Brings Important Insights for Treating Blood Disorders with Stem Cell Gene Therapy
A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia.
Agnès Viale, PhD
Associate Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology
Kevin J. Curran, MD
Assistant Attending, Pediatric Bone Marrow Transplant Service
Vladimir Bermudez, PhD
Laboratory Quality Assurance Coordinator
Senior Cell Manufacturing Technician
Get in Touch